Niaid DIR
Ended Awarded Last action
- Contract number
- 75N91020F00005
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $36,549,809
Award facts
- Contract value 97% obligated
- $37,520,022.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Institute of Allergy and Infectious Diseases National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $867,765 | |
| Funding Only Action | $1,250,000 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $8,076,491 | |
| Other Administrative Action | $2,000,000 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $7,435,945 | |
| Other Administrative Action | $353,028 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $7,525,958 | |
| Other Administrative Action | $1,058,065 | |
| Funding Only Action | $1,100,000 | |
| Other Administrative Action | $0 | |
| Original award | $6,882,557 |
Show all 15
About this award
This is a cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract has a ceiling value of $37,520,022 and a period of performance through August 30, 2024. The contract does not have a set-aside designation.
Leidos Biomedical Research Inc. is an FFRDC (Federally Funded Research and Development Center) contractor for the National Cancer Institute (NCI) and provides a range of research, development, and production services to federal agencies, with a focus on supporting biomedical research programs at the NIH. The contract work will be primarily performed at Leidos Biomedical Research facilities in Fort Detrick and Frederick, Maryland. The contract supports NIH research efforts across various disease areas such as cancer, HIV/AIDS, influenza, COVID-19, and gene therapy.
Quick answers
Who was awarded contract 75N91020F00005?
75N91020F00005 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on August 31, 2020.
How much is contract 75N91020F00005 worth?
The government has obligated $36,549,809 on 75N91020F00005. Its current value, with exercised options, is $37,520,022.
Which agency awarded contract 75N91020F00005?
National Cancer Institute (National Institutes of Health) awarded 75N91020F00005, with funding from National Institute of Allergy and Infectious Diseases (National Institutes of Health).
Is contract 75N91020F00005 an order under another contract?
Yes. 75N91020F00005 is a delivery order under 75N91019D00024, an indefinite delivery contract.
Was contract 75N91020F00005 competed?
The extent of competition for 75N91020F00005 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award